My Favorite Moment at ASH 2015

| Carlene Pratt

I thoroughly enjoyed hearing Dr. Brian Durie’s abstract presentation on “Myeloma: Therapy, excluding Transplantation: Advances in Newly Diagnosed and Relapsed Myeloma.”  He presented that the combination of VELCADE® (bortezomib), Revilmid® (lenalidomide), and dexamethasone (also called VRd), with continuous maintenance of lenalidomide and dexamethasone significantly improves progression-free survival and overall survival. This VRd regimen along with […]